142 related articles for article (PubMed ID: 19928580)
1. [On the possibility of patient phenotyping on the basis of cytochrome p-450 1A2 isoenzyme activity using caffeine as the test substrate].
Filimonova AA; Ziganshina LE; Ziganshin AU; Chichirov AA
Eksp Klin Farmakol; 2009; 72(5):61-5. PubMed ID: 19928580
[TBL] [Abstract][Full Text] [Related]
2. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.
Faber MS; Fuhr U
Clin Pharmacol Ther; 2004 Aug; 76(2):178-84. PubMed ID: 15289794
[TBL] [Abstract][Full Text] [Related]
3. Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study.
Härtter S; Ursing C; Morita S; Tybring G; von Bahr C; Christensen M; Röjdmark S; Bertilsson L
Clin Pharmacol Ther; 2001 Jul; 70(1):10-6. PubMed ID: 11452239
[TBL] [Abstract][Full Text] [Related]
4. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets.
Lampe JW; King IB; Li S; Grate MT; Barale KV; Chen C; Feng Z; Potter JD
Carcinogenesis; 2000 Jun; 21(6):1157-62. PubMed ID: 10837004
[TBL] [Abstract][Full Text] [Related]
5. Assessment of CYP1A2 activity in clinical practice: why, how, and when?
Faber MS; Jetter A; Fuhr U
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):125-34. PubMed ID: 16128905
[TBL] [Abstract][Full Text] [Related]
6. Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?
De Kesel PM; Lambert WE; Stove CP
Clin Pharmacokinet; 2015 Jul; 54(7):771-81. PubMed ID: 25603821
[TBL] [Abstract][Full Text] [Related]
7. Validation of a high-performance liquid chromatography assay for quantification of caffeine and paraxanthine in human serum in the context of CYP1A2 phenotyping.
Koch JP; ten Tusscher GW; Koppe JG; Guchelaar HJ
Biomed Chromatogr; 1999 Jun; 13(4):309-14. PubMed ID: 10416066
[TBL] [Abstract][Full Text] [Related]
8. Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin.
Härtter S; Korhonen T; Lundgren S; Rane A; Tolonen A; Turpeinen M; Laine K
Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):300-4. PubMed ID: 17040215
[TBL] [Abstract][Full Text] [Related]
9. Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers.
Tan EK; Chua E; Fook-Chong SM; Teo YY; Yuen Y; Tan L; Zhao Y
Pharmacogenet Genomics; 2007 Nov; 17(11):1001-5. PubMed ID: 18075470
[TBL] [Abstract][Full Text] [Related]
10. Correlation of cytochrome P450 (CYP) 1A2 activity using caffeine phenotyping and olanzapine disposition in healthy volunteers.
Shirley KL; Hon YY; Penzak SR; Lam YW; Spratlin V; Jann MW
Neuropsychopharmacology; 2003 May; 28(5):961-6. PubMed ID: 12644842
[TBL] [Abstract][Full Text] [Related]
11. Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
Sinués B; Sáenz MA; Lanuza J; Bernal ML; Fanlo A; Juste JL; Mayayo E
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):159-66. PubMed ID: 10067814
[TBL] [Abstract][Full Text] [Related]
12. Caffeine raises the serum melatonin level in healthy subjects: an indication of melatonin metabolism by cytochrome P450(CYP)1A2.
Ursing C; Wikner J; Brismar K; Röjdmark S
J Endocrinol Invest; 2003 May; 26(5):403-6. PubMed ID: 12906366
[TBL] [Abstract][Full Text] [Related]
13. The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes.
Christensen M; Andersson K; Dalén P; Mirghani RA; Muirhead GJ; Nordmark A; Tybring G; Wahlberg A; Yaşar U; Bertilsson L
Clin Pharmacol Ther; 2003 Jun; 73(6):517-28. PubMed ID: 12811361
[TBL] [Abstract][Full Text] [Related]
14. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism.
Benowitz NL; Peng M; Jacob P
Clin Pharmacol Ther; 2003 Nov; 74(5):468-74. PubMed ID: 14586387
[TBL] [Abstract][Full Text] [Related]
15. New specific marker of cytochrome P450 1A2 activity.
Filimonova AA; Ziganshina LE; Ziganshin AU; Chichirov AA
Bull Exp Biol Med; 2011 Apr; 150(6):762-4. PubMed ID: 22235437
[TBL] [Abstract][Full Text] [Related]
16. Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.
Backman JT; Karjalainen MJ; Neuvonen M; Laitila J; Neuvonen PJ
Br J Clin Pharmacol; 2006 Sep; 62(3):345-57. PubMed ID: 16934051
[TBL] [Abstract][Full Text] [Related]
17. The in-vivo effects of sho-saiko-to, a traditional Chinese herbal medicine, on two cytochrome P450 enzymes (1A2 and 3A) and xanthine oxidase in man.
Saruwatari J; Nakagawa K; Shindo J; Nachi S; Echizen H; Ishizaki T
J Pharm Pharmacol; 2003 Nov; 55(11):1553-9. PubMed ID: 14713367
[TBL] [Abstract][Full Text] [Related]
18. Activities of cytochrome P450 1A2, N-acetyltransferase 2, xanthine oxidase, and cytochrome P450 2D6 are unaltered in children with cystic fibrosis.
Kennedy MJ; Scripture CD; Kashuba AD; Scott CS; Gaedigk A; Kearns GL
Clin Pharmacol Ther; 2004 Mar; 75(3):163-71. PubMed ID: 15001967
[TBL] [Abstract][Full Text] [Related]
19. [Advance in cytochrome P450 1A2].
Xiao P; Zhou HH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):456-60. PubMed ID: 18544853
[TBL] [Abstract][Full Text] [Related]
20. Why dried blood spots are an ideal tool for CYP1A2 phenotyping.
De Kesel PM; Lambert WE; Stove CP
Clin Pharmacokinet; 2014 Aug; 53(8):763-71. PubMed ID: 24980692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
